(Q39478696)

12 September 2017

title

Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter (English)

1 reference

12 September 2017

0 references

Ellenbogen KA

1

1 reference

12 September 2017

Dias VC

2

1 reference

12 September 2017

Cardello FP

3

1 reference

12 September 2017

Strauss WE

4

1 reference

12 September 2017

Simonton CA

5

1 reference

12 September 2017

Pollak SJ

6

1 reference

12 September 2017

Wood MA

7

1 reference

12 September 2017

Stambler BS

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

American Journal of Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

75

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

45-49

1 reference

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Different cardiodepressant potency of various calcium antagonists in human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

The diltiazem-digoxin interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980525-6

10.1016/S0002-9149(99)80525-6

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference